The U.S. has exempted another 18 medical devices or device components from the 25% tariffs imposed on Chinese goods by the Trump administration. The new list includes ultrasound, X-ray, MRI and infusion equipment. The Office of the U.S. Trade Representative (USTR) said the new exclusions are retroactive to August 23, 2018, when additional tariffs went […]
Varian Medical Systems
Varian wins tariff exclusion for radiotherapy components
Varian Medical (NYSE:VAR) today said the U.S. Trade Representative granted exclusion of its radiotherapy system components from China in the latest tariffs. Palo Alto, Calif.-based Varian said components sourced from China for its linear accelerators manufactured in the U.S. were granted exemption from Section 301 of the tariffs. The exemption took place on Sept. 20. “We […]
Varian backs Oncora, launches Ethos radiotherapy device
Varian Medical (NYSE:VAR) said last week that it invested an unspecified amount in Oncora Medical and launched its Ethos artificial intelligence radiotherapy device. Philadelphia-based Oncora makes software used to plan radiotherapy procedures. Palo Alto, Calif.-based Varian said the partnership with Oncora is aimed at accelerating its software development for radiation oncology. “We envision a world where all […]
Medical linear accelerator makers gain on exemption from Chinese tariffs
Senior editor Nancy Crotti contributed to this report. UPDATED Sept. 16, 2019, with comment from Accuray. Shares in Varian Medical (NYSE:VAR), Accuray (NSDQ:ARAY) and Elekta (STO:EKTA B) gained this week after China added medical linear accelerators to a list of 16 products exempted from its trade war with the U.S. The parties appeared to be edging back to […]
Varian closes $90m microspheres buy from Boston Scientific
Hot on the heels of the $4 billion buyout of BTG by Boston Scientific (NYSE:BSX), Varian (NYSE:VAR) said yesterday that it closed the $90 million acquisition of Boston’s microspheres business. The deal for the drug-eluting and “bland” embolic microsphere business, which includes the Oncozene, Embozene and Embozone Tandem products, was struck to mollify anti-trust regulators about the BTG […]
Boston Scientific to deal microspheres to Varian Medical for $90m
UPDATED July 2, 2019, with financial details, comment from Varian. Looking to mollify anti-trust regulators about its pending $4 billion merger with BTG (LON:BTG), Boston Scientific (NYSE:BSX) said today that it agreed to deal its microsphere assets to Varian Medical (NYSE:VAR) for $90 million. The deal for the drug-eluting and “bland” embolic microsphere business includes Marlborough, Mass.-based Boston […]
Varian closes $283m Cancer Treatment Services buyout
Varian Medical (NYSE:VAR) said today that it closed the $283 million deal to acquire Cancer Treatment Services International and its network of oncology centers on the Indian subcontinent. When it announced the buyout last month, Varian said that it hoped to increase its expertise in cancer care center operations. The deal was financed via a credit facility […]
Varian adds to cancer care portfolio with $185m acquisition
Varian Medical (NYSE:VAR) said this week that it purchased two companies – Endocare and Alicon – to add to its cancer care solutions portfolio. The $185 million acquisition was financed with cash and proceeds from borrowings. Combined, Endocare and Alicon reeled in $30 million in revenues last year. Texas-based Endocare provides hardware and softwre for cryoablation […]
Varian Medical to pick up Cancer Treatment Services Int’l for $283m
Varian Medical (NYSE:VAR) said today that it inked a deal to acquire Cancer Treatment Services International for $283 million. Privately held CTSI operates the Hyderabad-based American Oncology Institute and 10 multidisciplinary radiation, medical and surgical oncology cancer centers across the Indian subcontinent and a U.S.-based oncology solutions division, Palo Alto, Calif.-based Varian said. Varian said that […]
Varian acquires CyberHeart, inks deal with China’s Shangdong Cancer Hospital
Varian Medical (NYSE:VAR) said today that it acquired privately-held CyberHeart and its cardiac radioablation tech, and that it inked a cooperative deal with China’s Shangdong Cancer Hospital for proton therapy applications and research. Palo Alto, Calif.-based Varian said that early clinical evidence from studies of CyberHeart’s cardiac radioablation technology indicated it “has the potential to offer […]
Varian shares dip on mixed-bag Q2 earnings
Shares in Varian Medical (NYSE:VAR) have fallen slightly today after the medical device maker posted fiscal year 2019 second quarter earnings that topped sales expectations but missed on earnings per share consensus on Wall Street. The Palo Alto, Calif.-based company posted profits of $88.4 million, or 96¢ per share, on sales of $779.4 million for the […]
